URGN icon

UroGen Pharma
URGN

Overview Fund Trends Analyst Outlook Journalist POV

21 hedge funds and large institutions have $85.2M invested in UroGen Pharma in 2017 Q2 according to their latest regulatory filings, with 21 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$26.2M
2
+$13.9M
3
+$13.6M
4
HCM
Highline Capital Management
New York
+$7.68M
5
HIM
Hillhouse Investment Management
Cayman Islands
+$6.36M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$26.2M
2
$13.9M
3
$13.6M
4
$7.68M
5
$6.36M
6
$4.86M
7
$3.17M
8
$2.44M
9
$2.33M
10
$903K
11
$856K
12
$695K
13
$594K
14
$540K
15
$500K
16
$221K
17
$195K
18
$136K
19
$7K
20
$7K
21
$5K